Portfolio company
HumGel
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company produces human tumor-derived hydrogels for researchers and pharmaceutical innovators to use in 3D cell culture and drug testing.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Humeltis
This company develops three-dimensional lung tissue models for pharmaceutical research, toxicology testing and personalised medicine for biotechnology and healthcare organisations.
Iscaff Pharma
This company develops patient-derived tumor scaffolds for pharmaceutical firms to improve the pre-clinical validation and development of aggressive cancer treatments.
Hooke Bio
This company develops a microfluidic platform using three-dimensional human tissue models for preclinical drug testing for pharmaceutical and biotechnology organisations.
Organo-ID
The company develops 3D organoid models and drug response tests for cancer patients and pharmaceutical researchers to improve personalised medicine and treatment efficacy.
BioHive
BioHive provides skin organoids derived from stem cells to pharmaceutical and dermocosmetic companies for toxicity and efficacy testing.
Prometheus Life Technologies
The company produces human tissue organoids in microgravity for pharmaceutical researchers to improve drug development, testing and regenerative medicine.
Carcinotech
Carcinotech manufactures 3D-bioprinted, patient-derived tumour models for drug developers and oncologists to perform rapid and ethical cancer drug testing and personalised medicine.
iOrganBio
This company develops an artificial intelligence-guided manufacturing platform to produce engineered human cells and organoids for biopharmaceutical researchers and clinical partners.